Royalty Pharma PLC (RPRX)
27.61
+0.14
(+0.51%)
USD |
NASDAQ |
Apr 17, 16:00
27.61
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Revenue (TTM): 2.355B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.355B |
| September 30, 2023 | 2.324B |
| June 30, 2023 | 2.361B |
| March 31, 2023 | 2.359B |
| December 31, 2022 | 2.237B |
| September 30, 2022 | 2.247B |
| June 30, 2022 | 2.259B |
| March 31, 2022 | 2.278B |
| December 31, 2021 | 2.289B |
| Date | Value |
|---|---|
| September 30, 2021 | 2.286B |
| June 30, 2021 | 2.239B |
| March 31, 2021 | 2.195B |
| December 31, 2020 | 2.122B |
| September 30, 2020 | 2.008B |
| June 30, 2020 | 1.934B |
| March 31, 2020 | 1.880B |
| December 31, 2019 | 1.814B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.814B
Minimum
Dec 2019
2.361B
Maximum
Jun 2023
2.188B
Average
2.247B
Median
Sep 2022
Revenue (TTM) Benchmarks
| Viatris Inc | 15.43B |
| Walgreens Boots Alliance Inc | 144.60B |
| Pacira BioSciences Inc | 674.98M |
| Amphastar Pharmaceuticals Inc | 644.40M |
| Maravai LifeSciences Holdings Inc | 288.94M |